Literature DB >> 31520612

Factors to Consider in Development of Drugs for Pediatric Nonalcoholic Fatty Liver Disease.

Miriam B Vos1, Lara Dimick-Santos2, Ruby Mehta2, Stephanie O Omokaro2, Johannes Taminiau3, Elmer Schabel4, David E Kleiner5, Peter Szitanyi6, Piotr Socha7, Jeffrey B Schwimmer8, Stephanie Noviello9, Debra G Silberg10, Richard Torstenson11, Veronica Miller12, Joel E Lavine13.   

Abstract

Entities:  

Mesh:

Year:  2019        PMID: 31520612      PMCID: PMC8996263          DOI: 10.1053/j.gastro.2019.08.048

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  54 in total

1.  Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population.

Authors:  Lidia S Szczepaniak; Pamela Nurenberg; David Leonard; Jeffrey D Browning; Jason S Reingold; Scott Grundy; Helen H Hobbs; Robert L Dobbins
Journal:  Am J Physiol Endocrinol Metab       Date:  2004-08-31       Impact factor: 4.310

2.  Abnormal liver function in children with metabolic syndrome from a UK-based obesity clinic.

Authors:  Christina Wei; Anna Ford; Linda Hunt; Elizabeth C Crowne; Julian P H Shield
Journal:  Arch Dis Child       Date:  2010-11-19       Impact factor: 3.791

Review 3.  Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies.

Authors:  Siddharth Singh; Alina M Allen; Zhen Wang; Larry J Prokop; Mohammad H Murad; Rohit Loomba
Journal:  Clin Gastroenterol Hepatol       Date:  2014-04-24       Impact factor: 11.382

4.  Association between puberty and features of nonalcoholic fatty liver disease.

Authors:  Ayako Suzuki; Manal F Abdelmalek; Jeffrey B Schwimmer; Joel E Lavine; Ann O Scheimann; Aynur Unalp-Arida; Katherine P Yates; Arun J Sanyal; Cynthia D Guy; Anna Mae Diehl
Journal:  Clin Gastroenterol Hepatol       Date:  2012-02-14       Impact factor: 11.382

5.  Design and validation of a histological scoring system for nonalcoholic fatty liver disease.

Authors:  David E Kleiner; Elizabeth M Brunt; Mark Van Natta; Cynthia Behling; Melissa J Contos; Oscar W Cummings; Linda D Ferrell; Yao-Chang Liu; Michael S Torbenson; Aynur Unalp-Arida; Matthew Yeh; Arthur J McCullough; Arun J Sanyal
Journal:  Hepatology       Date:  2005-06       Impact factor: 17.425

6.  Nonalcoholic fatty liver disease in children: a single center experience.

Authors:  Hassan H A-Kader; Jeff Henderson; Kathy Vanhoesen; Fayez Ghishan; Achyut Bhattacharyya
Journal:  Clin Gastroenterol Hepatol       Date:  2008-05-16       Impact factor: 11.382

7.  Incidence and natural course of fatty liver in the general population: the Dionysos study.

Authors:  Giorgio Bedogni; Lucia Miglioli; Flora Masutti; Anna Castiglione; Lory Saveria Crocè; Claudio Tiribelli; Stefano Bellentani
Journal:  Hepatology       Date:  2007-11       Impact factor: 17.425

8.  Noninvasive fatty liver markers predict liver disease mortality in the U.S. population.

Authors:  Aynur Unalp-Arida; Constance E Ruhl
Journal:  Hepatology       Date:  2016-01-22       Impact factor: 17.425

Review 9.  The Prevalence of Non-Alcoholic Fatty Liver Disease in Children and Adolescents: A Systematic Review and Meta-Analysis.

Authors:  Emma L Anderson; Laura D Howe; Hayley E Jones; Julian P T Higgins; Debbie A Lawlor; Abigail Fraser
Journal:  PLoS One       Date:  2015-10-29       Impact factor: 3.240

Review 10.  Pediatric non-alcoholic fatty liver disease: an increasing public health issue.

Authors:  S Berardis; E Sokal
Journal:  Eur J Pediatr       Date:  2013-09-26       Impact factor: 3.183

View more
  4 in total

Review 1.  Advancing the global public health agenda for NAFLD: a consensus statement.

Authors:  Jeffrey V Lazarus; Henry E Mark; Quentin M Anstee; Juan Pablo Arab; Rachel L Batterham; Laurent Castera; Helena Cortez-Pinto; Javier Crespo; Kenneth Cusi; M Ashworth Dirac; Sven Francque; Jacob George; Hannes Hagström; Terry T-K Huang; Mona H Ismail; Achim Kautz; Shiv Kumar Sarin; Rohit Loomba; Veronica Miller; Philip N Newsome; Michael Ninburg; Ponsiano Ocama; Vlad Ratziu; Mary Rinella; Diana Romero; Manuel Romero-Gómez; Jörn M Schattenberg; Emmanuel A Tsochatzis; Luca Valenti; Vincent Wai-Sun Wong; Yusuf Yilmaz; Zobair M Younossi; Shira Zelber-Sagi
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-10-27       Impact factor: 46.802

Review 2.  Perspectives on youth-onset nonalcoholic fatty liver disease.

Authors:  Eduardo Castillo-Leon; Catherine E Cioffi; Miriam B Vos
Journal:  Endocrinol Diabetes Metab       Date:  2020-09-17

3.  Randomized placebo-controlled trial of losartan for pediatric NAFLD.

Authors:  Miriam B Vos; Mark L Van Natta; Niviann M Blondet; Srinivasan Dasarathy; Mark Fishbein; Paula Hertel; Ajay K Jain; Saul J Karpen; Joel E Lavine; Saeed Mohammad; Laura A Miriel; Jean P Molleston; Marialena Mouzaki; Arun Sanyal; Emily P Sharkey; Jeffrey B Schwimmer; James Tonascia; Laura A Wilson; Stavra A Xanthakos
Journal:  Hepatology       Date:  2022-02-28       Impact factor: 17.298

4.  Burden of non-alcoholic steatohepatitis among children with type 2 diabetes mellitus.

Authors:  Lauren Parlett; Qinli Ma; Qian Shi; Geoffrey Crawford; Laura Herrera Scott; Vincent Willey; Abiy Agiro
Journal:  Diabetol Metab Syndr       Date:  2021-04-21       Impact factor: 3.320

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.